Protracted akathisia after risperidone withdrawal. 1997

P I Rosebush, and K Kennedy, and B Dalton, and M F Mazurek

UI MeSH Term Description Entries
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance
D017109 Akathisia, Drug-Induced A condition associated with the use of certain medications and characterized by an internal sense of motor restlessness often described as an inability to resist the urge to move. Pseudoakathisia,Acathisia, Drug-Induced,Akathisia, Tardive,Drug-Induced Akathisia,Acathisia, Drug Induced,Akathisia, Drug Induced,Drug Induced Akathisia,Drug-Induced Acathisia,Tardive Akathisia
D018967 Risperidone A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA. R-64,766,R-64766,Risperdal Consta,Risperidal,Consta, Risperdal,R 64,766,R 64766,R64,766,R64766

Related Publications

P I Rosebush, and K Kennedy, and B Dalton, and M F Mazurek
January 2002, Actas espanolas de psiquiatria,
P I Rosebush, and K Kennedy, and B Dalton, and M F Mazurek
February 2019, Psychopharmacology bulletin,
P I Rosebush, and K Kennedy, and B Dalton, and M F Mazurek
May 1994, The American journal of psychiatry,
P I Rosebush, and K Kennedy, and B Dalton, and M F Mazurek
July 1999, Indian journal of psychiatry,
P I Rosebush, and K Kennedy, and B Dalton, and M F Mazurek
January 1999, Indian journal of psychiatry,
P I Rosebush, and K Kennedy, and B Dalton, and M F Mazurek
June 2011, The Annals of pharmacotherapy,
P I Rosebush, and K Kennedy, and B Dalton, and M F Mazurek
April 1983, Annals of neurology,
P I Rosebush, and K Kennedy, and B Dalton, and M F Mazurek
January 1980, Advances in experimental medicine and biology,
P I Rosebush, and K Kennedy, and B Dalton, and M F Mazurek
October 2007, Pediatric neurology,
P I Rosebush, and K Kennedy, and B Dalton, and M F Mazurek
March 1994, Movement disorders : official journal of the Movement Disorder Society,
Copied contents to your clipboard!